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Abstract: We proposed to develop a polycation lipid nanocarrier (PLN) with higher   transfection 
efficiency than our previously described polycation nanostrucutred lipid nanocarrier (PNLC). 
PLN was composed of triolein, cetylated low-molecular-weight polyethylenimine, and dio-
leoyl phosphatidylethanolamine. The physicochemical properties of PLN and the PLN/DNA 
complexes (PDC) were characterized. The in vitro transfection was performed in human lung 
adenocarcinoma (SPC-A1) cells, and the intracellular mechanism was investigated as well. The 
measurements indicated that PLN and PDC are homogenous nanometer-sized particles with a 
positive charge. The transfection efficiency of PDC significantly increased with the content of 
triolein and was higher than that of PNLC and commercial LipofectamineTM 2000. In particu-
lar, the transfection of PLN in the presence of 10% serum was more effective than that in its 
absence. With the help of specific inhibitors of chlorpromazine and filipin, the clathrin-dependent 
endocytosis pathway was determined to be the main contributor to the successful transfection 
mediated by PLN in SPC-A1 cells. The captured images verified that the fluorescent PDC was 
localized in the lysosomes and nuclei after endocytosis. Thus, PLN represents a novel efficient 
nonviral gene delivery vector.
Keywords: triolein, dioleoyl phosphatidylethanolalmine, polyethylenimine, lipid nanocarrier, 
mechanism
Introduction
Efficient and safe gene transfer to mammalian cells remains the most challenging 
aspect of successful gene therapy.1 Many gene delivery systems including viral and 
nonviral vectors have been developed for effective gene transfection.2–4 Viral vectors 
show dramatically high transfection efficiency and are commonly used as delivery 
modalities for in vivo gene delivery. However, their applications are limited due to 
their poor safety profiles for in vivo studies.2,5 Nonviral vectors are associated with 
fewer safety concerns and less immunogenicity.6,7 Moreover, they are easier to produce 
in clinically relevant quantities and have fewer restrictions on their capacity to carry 
DNA. In the past few years, the development of novel efficient nonviral vectors has 
attracted increasing attention, although their efficiency is not quite satisfactory.4,7
Cationic liposomes and polyethylenimine (PEI) are the most extensively inves-
tigated nonviral vectors.8–11 Cationic liposomes are composed of cationic lipids and 
dioleoyl phosphatidylethanolamine (DOPE). DOPE is essential in cationic liposomes 
because it can form the inverted hexagonal (HII) phase at low pH and destabilize the 
endosomal membrane, thereby enhancing the transfection efficiency.12,13 On the other 
hand, PEI is one of the most effective gene delivery polymers with efficient gene International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
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transfer activity.10,11 Uptake of the PEI/DNA complexes into 
mammalian cells is via the endosomal pathway, and they 
are released into the cytoplasma from endosomes due to 
the proton sponge effect.14,15 LPDII vectors and polycation 
liposomes have been developed by combining the advantages 
of liposomes and polycation,16–18 which provides an effec-
tive strategy for the development of a novel nonviral gene 
delivery system.
Triolein is a hydrophobic molecule that shows little inter-
action with water and perturbs phospholipids planar bilayers. 
Measured effects of triolein on the structure and properties 
of phosphatidylethanolamine membrane have verified that 
triolein could enhance the formation of the HII phase, which 
may be beneficial to destabilizing the endosomal membrane 
and enhancing gene transfection.19 Artificial lipoprotein has 
been developed with triolein and palmitoyl poly-L-lysine for 
gene delivery, and the transfection efficiency was comparable 
with that of commercial LipofectamineTM.20,21 In our labora-
tory we have developed a polycation nanostructured lipid 
nanocarrier (PNLC) composed of cetylated PEI, triolein, and 
egg yolk phosphatidylcholine, and the transfection efficiency 
was increased with the content of triolein, which implied 
the potential effect of triolein on gene delivery.22 However, 
the facilitating effect of triolein on the formation of the HII 
phase in phosphatidylethanolamine membrane has not been 
utilized in a nonviral gene delivery system.
In the present study, polycation lipid nanocarrier (PLN) 
was developed with DOPE, cetylated PEI, and triolein for 
efficient gene delivery. We hypothesized that the incorpora-
tion of triolein into PLN could favor the formation of the HII 
phase, thereby enhancing the gene transfection efficiency. 
The physicochemical properties of PLN and the PLN/DNA 
complexes (PDC) were characterized, and the transfection 
efficiency was evaluated in comparison with the commercial 
LipofectamineTM 2000. Moreover, the intracellular mecha-
nism of PDC and the cytotoxicity were evaluated in human 
lung adenocarcinoma (SPC-A1) cells to verify the effective-
ness of PLN in efficient gene delivery.
Materials and methods
Materials
Triolein was purchased from Sinopharm Chemical Reagent 
Co Ltd (Shanghai, China), branched low-molecular 
PEI (1200 Da, Sigma-Aldrich, St Louis, MO) was lyo-
philized before use, DOPE was provided by Lipoid, 
LipofectamineTM 2000 and RPMI1640 were purchased 
from Invitrogen (Carlsbad, CA), and fetal bovine serum 
(FBS) was supplied by Hyclone Co Ltd (Beijing, China). 
MTT (3-[4,5-dimethylthiazolyl-2]-2,5-diphenyl tetrazolium 
bromide) and Hoechst 33258 were supplied from Sigma- 
Aldrich (Shanghai, China). Ethanol and other chemicals 
were analytical grade and used without further purification. 
Plasmid pEGFP-N2 encoding the enhanced green fluores-
cent protein (GFP) and plasmid pGL3-luc encoding the 
luciferase were used as reporter genes to access transfection 
efficiency. The plasmids were amplified using Escherichia 
coli DH5α and purified using the Endo Free Kit to remove 
the bacterial endotoxins.
cell lines
SPC-A1 were purchased from the Shanghai Cell Institute, 
Chinese Academy of Sciences. The cells were maintained 
at 37°C with 5% CO2 and fully humidified conditions. 
SPC-A1 cells were cultured with RPMI1640 medium, sup-
plemented with 10% FBS (Hyclone), 100 unit/mL penicillin, 
and 100 µg/mL streptomycin (Gibco).
Preparation and characterization of PLN
The cetylated PEI 1200 (c-PEI) was synthesized as previously 
described.18 The synthesized c-PEI contained, on average, 28 
ethylene units and six cetyl groups. PLN was prepared by an 
emulsification solvent evaporation method. In brief, c-PEI, 
triolein, and DOPE (0.1:0.8:1, molar ratio) were dissolved 
in dichloromethane and then dropped into three volumes 
of double-distilled water under agitation. The mixture was 
emulsified by sonication with probe at 200 w for 5 minutes 
(JYD 650, China), and the organic solvent was evaporated 
under reduced pressure (Heidolph Laborata 4000, Germany) 
at 37°C until the solution was clear to yield PLN.
The size distribution and zeta potential values of PLN 
were measured by dynamic light scattering (DLS) using a 
NICOMPTM ZLS 380 instrument (Particle Sizing System). 
PLN was diluted with three volumes of double-distilled 
water and measured at room temperature. The scattering 
angle was 90°, and the results were displayed in a Gaussian 
model. Analysis was performed with the accompanied zpw 
388 software (Particle Sizing System).
The surface morphology of PLN was characterized by 
atomic force microscopy (AFM) (SPM-9500, Shimazu, 
Japan) in air at room temperature. Briefly, 3 µL of diluted 
PLN was pipetted on to the freshly cleaved mica, dried over-
night at room temperature, and then imaged under AFM. The 
AFM measurements were performed using tapping mode 
probes with constant amplitude. The images were recorded 
at the resonance frequency of the cantilever with a scan rate 
of 1 Hz and a resolution of 256 samples per line.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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Preparation and characterization of PLN/
DNA complex
The PDC were prepared as previously described.11,18 Briefly, 
1 µg of plasmid DNA was diluted in sterile distilled water, 
and PLN was mixed with the DNA solution at different N/P 
ratios (ratios of nitrogen atoms on PEI to phosphates on 
plasmid DNA). The mixture was incubated for 20 minutes at 
room temperature prior to further experiments. The formation 
of PDC at different N/P ratios was examined using agarose 
gel analysis. Samples equivalent to 250 ng plasmid DNA 
were loaded into each well of the agarose gel (0.8% in Tris-
Acetate-EDTA buffer). Electrophoresis was conducted for 
50 minutes at 100 volts at room temperature, and the mobil-
ity of PDC was visualized under an EC3 imaging system 
(UVP). The morphologic examination of PDC (N/P = 10) 
(1 µg/mL) was performed by AFM with tapping mode as 
described previously. In addition, the size distribution and 
zeta potential values of PDC (1 µg/mL) in double-distilled 
water were measured by the NICOMPTM ZLS 380 instru-
ment as well.
cell transfection
SPC-A1 cells were seeded into 24-well plates at 1 × 105 cells/
well in 0.5 mL of culture medium 24 hours prior to the trans-
fection. The culture medium was replaced with 1 mL FBS 
free RPMI 1640 medium before the transfection experiments. 
PDC equivalent to 1 µg of plasmid DNA at various N/P ratios 
were added to each well and incubated for 4 hours at 37°C 
and 5% CO2. Then, the incubation medium was removed and 
1 mL of fresh RPMI 1640 with 10% FBS was added to each 
well and incubated for a further 48 hours. Meanwhile, trans-
fection with LipofectamineTM 2000/DNA complexes (LDC) 
was performed according to the manufacturer’s protocol as 
positive control. The terminal concentration of plasmid DNA 
in each well was about 1 µg/mL. In addition, to evaluate the 
effect of serum on the transfection, PDC (N/P = 10) was 
incubated with cells for 4 hours in RPMI 1640 culture media 
with 10% FBS. Afterwards, the procedure was performed 
as described previously. All transfection experiments were 
performed in triplicate.
Evaluation of transfection efficiency
The GFP expression in SPC-A1 cells was directly observed 
under fluorescence microscope (Olympus IX71, Japan). 
Quantitative assay of expressed GFP in SPC-A1 cells was 
determined as previously described.18 Cells were washed 
twice with PBS in the culture plate, solubilized with 1% 
  Triton X-100 (Sigma) for 30 minutes at room temperature, 
and then centrifuged at 3000 × g for 10 minutes. The fluo-
rescence intensity in the supernatant was measured on a fluo-
rescence spectrometer (LS55, Perkin Elmer). The excitation 
wavelength was 493 nm, and the emission one was 510 nm. 
The lysate of SPC-A1 cells without any treatment was used 
as a negative control.
Moreover, the transfection of plasmid pEGFP-N2 medi-
ated by PDC was analyzed by flow cytometry.23 After 
48 hours’ incubation, cells were washed with cold PBS 
and harvested by the addition of trypsin-EDTA solution. 
Then, 1 mL of PBS was added and cells were centrifuged at 
1000 × g for 5 minutes. The cell pellets were washed three 
times with PBS and fixed in 2% para-formaldehyde solution 
for 30 minutes at 4°C. The fixed cells were washed twice 
with PBS and resuspended in 0.1% para-formaldehyde for 
subsequent analysis. The GFP expressed cells were measured 
using a FACScan flow cytometer (BD Biosciences) and ana-
lyzed with CellQuest software. A total of 10,000 cells were 
collected for each sample, and determination of GFP positive 
events was performed by a standard gating technique.
In addition, transfection of plasmid pGL3-luc in 
SPC-A1 cells by PDC was also preceded as described 
  previously. After an additional 48 hours’ incubation, 
SPC-A1 cells were lysated with 1% Triton X-100 at 4°C 
for 30 minutes, and the cell lysates were centrifuged at 
3000 × g for 10   minutes. The expressed luciferase activity in 
the supernatant was measured by the bioluminescence assay 
kit according to the protocol (Biotherma). Where indicated, 
luciferase activity was normalized for protein content using 
the BCA protein assay (Pierce). The relative transfection 
efficiency was expressed as the ratio between the expressed 
luciferase activity in SPC-A1 cells mediated by PDC and that 
transfected by LDC in the absence of serum.
Intracellular transfer mechanism
To investigate the endocytosis pathway of PDC, the transfec-
tion of PDC in SPC-A1 cells was performed in the presence 
of specific inhibitors.24,25 Chlorpromazine could disturb the 
intracellular clathrin processing and was used to inhibit the 
clathrin-dependent endocytosis. On the other hand, filipin III 
could complex with membrane cholesterol and interferes 
with the cholesterol-sensitive process, thereby blocking 
the caveolae-mediated endocytosis.26,27 SPC-A1 cells were 
preincubated with 10 µg/mL chlorpromazine or 1 µg/mL 
filipin III for 1 hour in serum free RPMI 1640 media. PLN 
was mixed with plasmid pGL3-luc for 20 minutes at room 
temperature to prepared PDC (N/P ratio = 10). Then, PDC 
was added to each well and incubated for another 2 hours International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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at 37°C. Afterwards, the incubation media were removed and 
cells were cultured with FBS-supplemented medium without 
any inhibitors. After further incubation for 48 hours, cells 
were lysated and the luciferase activity in the supernatant 
was determined as described previously. All transfection 
experiments were performed in triplicate. The expressed 
luciferase activity in SPC-A1 cells without the treatment of 
any inhibitor was set as 100%.
Laser confocal scanning microscopy
To visualize the localization of PDC in SPC-A1 cells, 
plasmid DNA was fluorescently labeled with Label IT® 
TM-Rhodamine Labeling Kit (Mirus) according to the manu-
facturer’s protocol, and the fluorescently labeled PDC were 
prepared as described previously. Approximately 5 × 105 cells 
were seeded into a 35 mm glass-bottom dish (MatTek) and 
cultured overnight prior to the experiments. Cells were incu-
bated in FBS containing RPMI1640 media without phenol 
red (Gibco). Before transfection experiments, the medium 
was replaced with FBS free culture media without phenol red. 
The fluorescently labeled PDC was added and incubated at 
37°C for 2 hours. Immediately before imaging, the lysosomes 
were labeled with LysoTrackerTM Green DND-26 (Molecular 
Probes), and the nuclei were stained with Hoechst 33258. 
Cells were washed twice with RPMI1640 media without 
phenol red prior to observation under laser confocal scanning 
microscopy (Leica Sp-5, Germany).28
cell cytotoxicity assay
The cytotoxicity of PDC in SPC-A1 cells was ascertained by 
MTT colorimetric assay.22,29 Cells were seeded in a 96-well 
cell culture plate at an initial density of 1 × 104 cells/well 
and incubated for 24 hours prior to the test. PDC at various 
N/P ratios was added to each well at 100 ng/well of plasmid 
DNA in 200 µL of serum free growth media, and then the 
process proceeded as described previously. Meanwhile, the 
cytotoxicity of different PEI (1200Da)/DNA complexes 
was determined as positive control. After 24 hours, cells 
were performed for MTT assay. The absorbance at 570 nm 
of each well was measured by a microplate reader (BioTek 
ELx800). The viability of SPC-A1 cells without any treat-
ment was set as 100%, and the cytotoxicity of PDC was 
calculated thereof.
Results
Preparation and characterization of PLN
PLN was constructed with cetylated low-molecular-weight 
PEI (1200 Da) (c-PEI), triolein, and DOPE, which could be 
composed of lipid core and hydrophilic surface at the outer 
shell (Figure 1A). The hydrophobic groups of amphiphilic 
c-PEI, DOPE, and lipophilic Triolein could form the lipid 
core due to the hydrophobic interaction, whereas the hydro-
philic groups of c-PEI and DOPE could surround at the outer 
surface. The lipophilic cetyl groups of c-PEI could facilitate 
its incorporation into the lipid nanocarrier and locate the 
cationic hydrophilic PEI on the surface. The mean diameter 
of PLN was 136 ± 44.8 nm with a narrow polydispersivity 
of 0.108 (Figure 1B). Meanwhile, the AFM measurements 
revealed that PLN was quasispherical nanometric particles 
(Figure 1C), and the particle size was in accordance with 
that measured by DLS. In addition, the zeta potential of PLN 
was 34.32 ± 2.13 mv, which could facilitate the compaction 
of PLN with anionic plasmids DNA for subsequent gene 
transfection. The cationic potential of PLN implicated that 
the hydrophilic cationic PEI groups of c-PEI could locate at 
the surface of the lipid nanocarrier.
After PLN was mixed with plasmid DNA to form the 
PDC, the mean diameter of PDC (N/P ratio = 10) was 
228.1 ± 58.7 nm with a narrow polydispersivity of 0.066 
(  Figure 1D), and the zeta potential value was 11.92 ± 1.12 mv. 
In addition, no aggregation or precipitation was observed in the 
measurements. The AFM measurements confirmed that PDC 
(N/P ratio = 10) had nanometer-sized particles (  Figure 1E), and 
no free PLN or plasmid DNA was observed. The particle size 
of PDC measured by AFM was accorded with that determined 
by DLS. Considering the narrow size distribution and positive 
potential value of PDC, the plasmid DNA could be condensed 
at the surface of PLN. The nanometric size and positive surface 
charge of PDC could be beneficial to the cellular uptake and 
gene transfection. Moreover, the formation of PDC at various 
N/P ratios was analyzed by gel retardation assay (Figure 1F). 
The electrophoresis images revealed that the bands of plasmids 
DNA disappeared in PDC when the N/P ratio was more than 
10, which indicated that the anionic plasmid DNA molecules 
could be condensed by PLN.
Transfection efficiency of PDC
The GFP expression in SPC-A1 cells after transfection 
with the PDC was observed under fluorescence microscopy. 
The experimental results indicated that GFP was expressed 
24 hours after transfection with the highest expression from 
the second to the fourth day. Many cells were fluorescence 
positive after treated with the LDC or PDC (Figure 2A and B). 
The fluorescence intensity expressed GFP in SPC-A1 cells 
was quantified by fluorescence spectrum (Figure 2C). The 
GFP fluorescence intensity in SPC-A1 cells transfected by International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
Dovepress 
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PDC at an N/P ratio of 5 was much lower than that at an 
N/P ratio of 10 (data not shown), which could result from 
the incomplete condensation of plasmid DNA at an N/P 
ratio of 5. Moreover, the transfection efficiency of PDC was 
highest at an N/P ratio of 10 and significantly decreased with 
the increase in ratio. The reason may lie in the appropriate 
protection of plasmid DNA by PDC against degradation, 
unpackaging of the complexes, and its cytoplasmic transfer 
character. When no triolein was introduced to the formula-
tion, the GFP fluorescence intensity of PDC (N/P = 10) was 
comparable with that of commercial LDC. However, after 
the incorporation of triolein into the PLN formulation, the 
GFP fluorescence intensity was increased with the content 
of triolein in PLN and reached the highest when the molar 
ratio of triolein/DOPE was 0.8, which was two-fold higher 
than that of LDC (P , 0.01). However, the transfection 
efficiency was decreased unexpectedly when the molar ratio 
of triolein/DOPE was over 0.8, which could be correlated 
with the effect of triolein on DOPE and the physicochemical 
properties of PLN.
Furthermore, the transfection efficiency of PDC in 
SPC-A1 cells was quantified by monitoring GFP positive 
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Figure 1 characteristics of polycation lipid nanocarrier (PLN) and PLN/DNA complexes (PDc). (A) scheme of PLN composed of cetylated polyethylenimine (PeI) 1200 
(c-PeI), dioleoyl phosphatidylethanolamine (DOPe), and triolein; (B) size distribution of PLN; (C) atomic force microscopy image of PLN, scale bar = 1.0 µm; (D) size 
distribution of PDc (N/P ratio = 10); (E) atomic force microscopy image of the PDc (N/P ratio = 10), scale bar = 1.0 µm; (F) agarose gel electrophoresis of the complexes 
of PLN with plasmid DNA stained with ethidium bromide.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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cell counts compared with those of LDC. The flow cytometry 
  measurements indicated that GFP positive cells transfected by 
PDC reached about 40%, which was significantly higher than 
that achieved by LDC (P , 0.05) (Figure 3A). In the presence of 
10% serum, the transfection efficiency of PDC in SPC-A1 cells 
was 199% of that in its absence (P , 0.05), whereas that of 
LDC was reduced by about 70% compared with that in the 
absence of serum (P , 0.05). Likewise, the gene expression 
intensity was quantified by measuring the activity of expressed 
luciferase in SPC-A1 cells. It could be noticed that the gene 
expression intensity mediated by PDC was 3.8-fold higher than 
that of LDC (Figure 3B) (P , 0.01). The expressed luciferase 
activity in SPC-A1 cells transfected by PDC in the presence of 
10% serum was 222% of that in its absence (P , 0.05).
To evaluate the potential cytotoxicity of PDC in 
SPC-A1 cells, the cell viability was tested by MTT colorimetric 
assay after cells were treated with PDC at various N/P ratios.23 
Cells incubated with pure culture media were considered 
  controls. The cell viability of PDC was over 70% when the N/P 
ratio was less than 250, and was significantly higher than that 
of PEI/DNA complexes at various N/P ratios, which indicated 
that PDC exhibited minimal cytotoxicity in SPC-A1 cells.
Intracellular transfer mechanism  
in sPc-A1 cells
The internalization pathway of PDC could affect their 
intracellular processing and subsequent gene expression as 
well.24,25 To determine the internalization mode of PDC in 
SPC-A1 cells, transfection of plasmid pGL3-luc was per-
formed in the presence of specific inhibitors of chlorpromaz-
ine (Chlor) and filipin III. Because the specificity and toxicity 
of the endocytic inhibitors varied with the cell lines, the 
viability of SPC-A1 cells treated with the endocytic inhibitors 
was over 80%, and their specificity in SPC-A1 cells was also 
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confirmed in our preliminary experiments. Interestingly, the 
transfection efficiency of PDC evidently decreased by about 
90% in the presence of chlorpromazine (Figure 4) (P , 0.01) 
but was not significantly reduced after the treatment of 
filipin III (Figure 4) (P . 0.05). Moreover, treatment with 
both the inhibitors led to 86% reduction of the transfection 
efficiency in comparison with that in their absence (Figure 4) 
(P , 0.01). Now it appears that PDC was mainly endocytosed 
via the clathrin-mediated pathway in SPC-A1 cells.
Internalization of PDc in sPc-A1 cells
The localization of internalized PDC in SPC-A1 cells 
was investigated to clarify its intracellular mechanism. 
Plasmid DNA was labeled with red TM-Rhodamine, and the 
  fluorescent PDC (N/P = 10) was prepared as described for 
direction observation under laser scanning confocal micros-
copy (LCSM). As a control, the late endosomes/lysosomes 
were stained with LysoTracker Green DND-26 (green), and 
the nuclei were counterstained with Hoechst 33258 (blue). 
Because the red fluorescence of TM-Rhodamine labeled PDC 
(Figure 5A) could be easily distinguished from the green 
fluorescence of LyosTracker Green DND-26 (Figure 5B), 
colocalization of PDCs with the late endosomes/lysosomes 
would yield yellow spots (combination of red and green). 
Two hours after incubation, yellow spots were obviously 
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visible in the cytoplasma (Figure 5D), which confirmed the 
colocalization of PDCs with late endosomes/lysosomes. 
However, no fluorescently labeled PDC was observed in the 
nuclei within 2 hours. The spots with different colors may 
exhibit the different distribution of PDC in SPC-A1 cells. 
Furthermore, after 6 hours’ incubation, the LCSM images 
revealed that the TM-Rhodamine labeled PDC was obviously 
located in the nucleus (Figure 6).
Discussion
Colloidal particle systems have many advantages as potential 
candidates for efficient nonviral gene delivery.4,8,30,31 The 
nano-based nonviral vectors, including artificial lipoprotein, 
polycation liposome, and LPDII vectors, could offer an 
effective method to integrate the advantages of lipids and 
cationic polymers. Recently, we have developed nanostruc-
tured lipid carriers modified with c-PEI for gene delivery, 
and the transfection efficiency was comparable with LDC.22 
DOPE, an essential component of cationic liposomes, could 
form the HII phase and destabilize the endosomal mem-
brane, thereby enhancing the transfection efficiency.12,13 In 
particular, triolein could facilitate the formation of the HII 
phase in the phosphatidylethanolamine membrane,19 which 
could avail the destabilization of the endosomal membrane 
and improvement of the gene delivery activity. On the other 
hand, PEI could deliver DNA to the nucleus after escap-
ing from the endosomal pathway due to the proton sponge 
effect.4,14,15 Alkylation or carboxyalkylation could be effec-
tive methods to modify PEI for higher transfection efficiency 
and lower cytotoxicity.4,14,32,33 In the present study, PLN was 
developed by the combination of the advantages of cetylated 
PEI, triolein, and DOPE, which could integrate the effect of 
the HII phase and the proton sponge effect to destabilize the 
endosomal membrane for effective gene delivery.
From the transfection results of plasmid pEGFP-N2 and 
pGL3-luc in SPC-A1 cells, we learned that the transfec-
tion efficiency of PLN was significantly improved after 
the incorporation of triolein in the formulation. When no 
triolein was introduced in the formulation, the nanocarrier 
was similar to the previously reported polycation liposomes, 
and the transfection efficiency was only about 30% of that 
of PLN (0.1:0.8:1, molar ratio). Interestingly, the transfec-
tion efficiency of PLN was significantly increased with the 
addition of triolein in PLN, which obviously verified the 
effectiveness of triolein in enhancing the gene transfection 
efficiency of PLN. Triolein could perturb the structure of 
phospholipids planar bilayers and facilitate the formation 
of the HII phase,19 which could destabilize the endosomal 
membrane and enhance the gene transfection efficiency. 
Moreover, the gene delivery activity of PLN was more 
effective than our previously described PNLC composed of 
c-PEI, triolein, and egg yolk phosphatidylcholine,22 which 
identified the essentiality of DOPE in PLN. Additionally, the 
transfection efficiency of PLN was much higher than that of 
commercial LipofectamineTM 2000, consisting of cationic 
lipid and DOPE, which certified the outstanding effect of 
cetylated PEI and triolein in PLN-mediated gene delivery. 
Taken together, this evidence indicated that PLN could com-
bine the advantages of cetylated PEI, triolein, and DOPE for 
effective gene delivery.
Surprisingly, the transfection efficiency of PLN was 
obviously augmented in the presence of 10% serum, but 
that of the commercial LipofectamineTM 2000 was sharply 
decreased, which indicated the PLN’s potential for in vivo 
gene delivery. Previous reports suggested that dodecylation 
and hexadecylation of PEI (2000 Da) could enhance the gene 
transfection in the presence of serum by five- to six-fold com-
pared with the unmodified PEI (25,000 Da).15 Moreover, the 
resistance against serum has been observed in the transfection 
of previously described PNLC with cetylated PEI (1200 Da) 
and polycation liposomes containing cetylated PEI (600 Da 
or 1800 Da).17,18,22 The enhanced transfection of PLN in the 
presence of serum could result from c-PEI involvement in 
the PLN formulation.
To clarify internalization pathways of PDC in efficient 
gene delivery, we performed reporter gene transfection 
in SPC-A1 cells in the presence of specific inhibitors.26,27 
  Chlorpromazine was commonly used to inhibit clathrin-
dependent endocytosis, and filipin III could specifically block 
caveolae-mediated uptake. The experimental results indicated 
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Figure 6 colocalization of polycation lipid nanocarrier/DNA complexes (PDc) 
(N/P = 10) with nucleus in human lung adenocarcinoma (sPc-A1) cells under laser 
scanning confocal microscopy at 6 hours after transfection. (A) TM-rhodamine 
labeled plasmid DNA (red); (B) hoechst 33258 labeled nuclei (blue); (C) phase-
contrast image of sPc-A1 cells; (D) merged image, scale bar = 25 µm.International Journal of Nanomedicine 2011:6 submit your manuscript | www.dovepress.com
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that the transfection efficiency of PDC was remarkably 
reduced in SPC-A1 cells treated with chlorpromazine but not 
significantly decreased in the presence of filipin III. Thereby, 
it could be deduced that PDC could be predominantly inter-
nalized through a clathrin-dependent endocytosis pathway in 
SPC-A1 cells for efficient gene transfection. The LCSM images 
indicated that PDC was colocalized with the late endosome/
lysosomes after their endocytosis in SPC-A1 cells. These results 
suggested that PDC could be endocyted through the clathrin-
dependent pathway, which was different from the reported PEI 
  polyplexes.26 It has been reported that only caveolae/lipid-raft-
mediated uptake contributes to efficient transfection of PEI 
polyplexes.26 However, PLN was a hybrid nanocarrier system 
composed of cetylated PEI, triolein, and DOPE, rather than 
simple PEI. Moreover, Gersdorf et al27 have demonstrated that 
the internalization route resulting in successful gene expression 
depended on both cell lines and PEI polyplex type. The cell line 
could be another substantial reason for the different internaliza-
tion pathway of PDC in SPC-A1 cells. In our laboratory we have 
proven that the internalization pathway of PDC in SPC-A1 cells 
was different from that in Chinese hamster ovary cells (data 
not shown). Additionally, the LCSM images revealed that PLN 
could facilitate the gene entry into the nucleus to promote the 
transfection efficiency, which could contribute to the effect of 
cetylated PEI as per previously reported results.34
The cytotoxicity of nonviral vectors should also be 
considered for gene delivery. The toxicity of PEI was cor-
related with its molecular weight and cationic charge density. 
Various modifications have been performed to minimize the 
cytotoxicity of PEI, eg, alkylation, carboxyalkylation, or 
PEGylation.10,11,15,32,33 In the present formulation, the cetyla-
tion of low-molecular PEI (1200 Da) could significantly 
reduce the cytotoxicity; moreover, the involved DOPE and 
triolein were biocompatible components, which could result 
in the low toxicity of PLN. The measured results have indi-
cated that the cytotoxicity of PLN was much lower than the 
unmodified PEI (1200 Da), which was in agreement with 
that of previously described dodecylation of PEI (2000 Da) 
or polycation lipsosomes.14,15,17,18
Conclusion
In summary, PLN was developed by combining the advan-
tages of cetylated PEI, triolein, and DOPE for effective 
gene delivery. PLN and PDC were homogenous nanometric 
particles with a positive surface charge. The transfection effi-
ciency of PLN in SPC-A1 cells was significantly improved 
after the incorporation of triolein and much higher than the 
  commercial levels of LipofectamineTM 2000. With the help of 
specific inhibitors and images of LCSM, PDC was determined 
to be internalized into SPC-A1 cells by the clathrin-mediated 
pathway and then transferred to the nucleus for successful 
transfection. Thus, the triolein-based PLN demonstrated a 
novel effective gene delivery system.
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